BioHarvest Sciences (NASDAQ:BHST) Trading 0.9% Higher – Still a Buy?

Shares of BioHarvest Sciences Inc. (NASDAQ:BHST) were up 0.9% during trading on Monday . The company traded as high as $4.40 and last traded at $4.31. Approximately 19,419 shares traded hands during trading, an increase of 12% from the average daily volume of 17,297 shares. The stock had previously closed at $4.27.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of BioHarvest Sciences in a research report on Monday, December 29th. Roth Mkm began coverage on BioHarvest Sciences in a research note on Thursday, February 19th. They set a “buy” rating and a $10.00 price target on the stock. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $13.00.

BioHarvest Sciences Trading Up 0.9%

The firm has a market cap of $70.77 million, a PE ratio of -6.34 and a beta of 1.14. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.35 and a quick ratio of 1.02. The business has a 50-day moving average price of $4.69 and a two-hundred day moving average price of $6.79.

Hedge Funds Weigh In On BioHarvest Sciences

Several hedge funds have recently added to or reduced their stakes in the business. Alyeska Investment Group L.P. acquired a new position in BioHarvest Sciences during the fourth quarter worth about $3,929,000. Thompson Siegel & Walmsley LLC acquired a new stake in shares of BioHarvest Sciences in the fourth quarter valued at approximately $1,945,000. True North Advisors LLC grew its position in shares of BioHarvest Sciences by 676.1% in the third quarter. True North Advisors LLC now owns 168,013 shares of the company’s stock valued at $1,581,000 after purchasing an additional 146,365 shares during the last quarter. Evercore Wealth Management LLC purchased a new position in shares of BioHarvest Sciences during the 4th quarter worth approximately $724,000. Finally, King Luther Capital Management Corp acquired a new position in shares of BioHarvest Sciences during the 4th quarter worth approximately $208,000.

About BioHarvest Sciences

BioHarvest Sciences Inc is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets.